ARCHIVES

Immune Therapy Possible For Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002

Clinical Trials Approved By NCI

November 26, 2010

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982